Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of mRNA-1975 and mRNA-1982 Against Lyme Disease in Participants 18 Through 70 Years of Age [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 study by Moderna evaluated the safety and immunogenicity of two Lyme disease vaccine candidates, mRNA-1975 and mRNA-1982, in adults aged 1…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lyme Disease

Drugs mentioned

• mRNA-1975
• mRNA-1982

Snippet

Sponsor: ModernaTX, Inc. | Conditions: Lyme Disease | Phase 1, Phase 2 | Status: COMPLETED